Rezultati pretraživanja

  1. Osobe Vidi sve

  2. prije 15 minuta

    DGI For The DIY: 2019 Dividend Portfolio Review -

  3. prije 2 sata

    Chairman & CEO going nuts buying his stock. Interesting following rumors as operates in CKD space like

    1 reply
    Prikaži ovu nit
    Prikaži ovu nit
  4. prije 7 sati

    Follow 100 traders & track their tweets under one watchlist

  5. prije 8 sati

    So is now the most valuable company in the US. Also >>> , , or is still a bit unfathomable in my mind. Markets are markets though, who am I to judge.

  6. prije 10 sati

    GS Feb 24-27 west was Coast tour , , GRTS , VRTX, VIR BHC ,

    1 proslijeđeni tweet 4 korisnika označavaju da im se sviđa
  7. prije 19 sati

    Svb Leerink Research Analysts Decrease Earnings Estimates for Amgen, Inc.

  8. 3. velj

    What all my alerts have in common is, the all move big after alerting them to subscribers. etc

    2 korisnika označavaju da im se sviđa
  9. 2. velj

    Could Guardant Health Be a Millionaire-Maker Stock?

    2 korisnika označavaju da im se sviđa
  10. 1. velj

    My main longs in active trading accounts are . A couple of more with & hedges + 1/3 puts. Leaves with 85% cash.

    1 reply 1 proslijeđeni tweet 14 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  11. 1. velj

    stock was down -1.08 %. Turned Positive 0.38 % | (Red to green move) See other red to green mo ves using

  12. 31. sij

    asset watch - the large cap names of Friday trading -

  13. 31. sij

    GS: Note that AMGN typically guides conservatively. Buy any pullback. Three significant late-stage pipeline readouts this year, have potential to expand AMGN’s multiple. PT $273

    1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
  14. 31. sij

    Today's Pre-Market Movers & News [Friday, January 31st, 2020]: CHARTS & DISCUSSION! -> <-

  15. 30. sij

    Amgen, afterhours 1min

  16. 30. sij

    Outside huge earnings beat Lots of earnings misses

    8 korisnika označava da im se sviđa
  17. 30. sij

    revenues of $568m, of $738m and of $911m in 2019; looks like biosimilars are becoming material to the top line. But for each company it is a portfolio of products and US and Europe.

    6 proslijeđenih tweetova 10 korisnika označava da im se sviđa
  18. 30. sij

    Shocking revenue guidance low. as well, but don’t worry....

    1 reply 14 korisnika označava da im se sviđa
  19. 30. sij

    = watch👀

    2 korisnika označavaju da im se sviđa
  20. 29. sij

    My note to our subscribers nice call on: $322. $224, +$218.55 $245.3. $135🥂😊🙏

    1 reply 2 korisnika označavaju da im se sviđa

Nema rezultata.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.